BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:ADC innovation is accelerating beyond traditional cytotoxins i
 nto dual-payload constructs\, high-DAR species\, degrader-antibody conjug
 ates\, and next-generation modalities. However\, this rapid evolution is 
 placing unprecedented pressure on linker architecture and conjugation che
 mistry to control stability\, reduce off-target toxicity\, overcome tumor
  resistance\, and maintain manufacturability.\n\nTo meet these challenges
  head on\, the 4th ADC Linker and Conjugation Summit offers a highly tech
 nical\, deeply curated environment built specifically for specialists wor
 king at the cutting edge of ADC chemistry. At this summit\, you aren't lo
 st in a crowd\, you're surrounded by peers who share the same job titles\
 , scientific focus\, and day-to-day challenges. Every session is built fo
 r specialists\, every conversation is relevant\, and every detail is desi
 gned to advance real chemistry solutions.\n\nOver three focused days\, 80
 + ADC chemists\, protein engineers\, and translational scientists will di
 ssect the core chemistry questions shaping next generation ADC performanc
 e. With 20+ expert-led case studies from leading biopharma and biotech in
 novators\, you'll gain actionable insights to engineer homogeneous ADCs\,
  prevent premature payload release\, enable orthogonal dual payload syste
 ms\, mitigate hydrophobicity driven aggregation\, and integrate predictiv
 e modeling into platform design.\n\nThrough hands-on workshops\, technica
 l debates\, and collaborative networking\, this summit gives you the rare
  opportunity to shape the linker and conjugation strategies that will def
 ine the next decade of ADC development.\n\nDate and Time: Tuesday\, 28 Ju
 ly 2026 at 08:00 - Thursday\, 30 July 2026 at 16:00\n
DTEND:20260730T160000
DTSTAMP:20260512T220028Z
DTSTART:20260728T080000
LOCATION:Revere Hotel Boston Common\, 200 Stuart Street\, Boston\, Massach
 usetts\, 02116\,
SEQUENCE:0
SUMMARY:ADC innovation is accelerating beyond traditional cytotoxins into 
 dual-payload constructs\, high-DAR species\, degrader-antibody conjugates
 \, and next...
UID:3139873e-7df8-4401-963c-92a0d2e3c4b8
END:VEVENT
END:VCALENDAR